A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
University Health Network, Toronto
University Health Network, Toronto
Korea University Anam Hospital
National Cancer Centre, Singapore
Bristol-Myers Squibb
University College, London
A2 Biotherapeutics Inc.
Wageningen University
University Hospital, Antwerp
Humanitas Clinical and Research Center
Sun Yat-sen University